CareDx (CDNA) Tops Q1 EPS by 44c ; Offers Guidance

CareDx (NASDAQ: CDNA) reported Q1 EPS of ($0.03), $0.44 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $72 million versus the consensus estimate of $63.48 million.

GUIDANCE:

CareDx sees FY2024 revenue of $274-282 million, versus the consensus of $267 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• California Resources completes $63M acquisition of Crimson Midstream
• Credo Technology Group Holding (CRDO) Tops Q1 EPS by 4c; offers guidance